-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM PHARMACEUTICALS, INC. : JP MORGAN CUTS TARGET PRICE TO $369 FROM $375

Reuters·09/30/2026 04:38:00

Please log in to view news